• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核自身抗原性精子蛋白在铂耐药卵巢癌细胞克隆中的表达

[Expression of nuclear autoantigenic sperm protein in platinum resistance ovarian cancer cell clones].

作者信息

Wang Hui-xiang, Tan Yan

机构信息

Department of Obstetrics and Gynecology, Affiliated Yuquan Hospital of Tsinghua University, Beijing 100049, China.

出版信息

Zhonghua Yi Xue Za Zhi. 2010 Jan 5;90(1):61-3.

PMID:20356529
Abstract

OBJECTIVE

To study the expression of NASP in platinum resistance ovarian cancer cell clones (C0C1/DDP).

METHODS

The proteins of C0C1 and C0C1/DDP were separated by highly sensitive two-dimensional differential gel electrophoresis (2-D DIGE) coupled with matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF-MS) to identify the proteins differentially expressed in cisplatin sensitive and cisplatin resistance cell lines.

RESULTS

The investigators found a group of the distinct expressed proteins between C0C1 and C0C1/DDP. Among them, NASP was one of the down-regulated proteins by 21% (Student's t-test; P = 0.01).

CONCLUSION

The identification of NASP in C0C1/DDP has laid a foundation for future in-depth researches into the mechanisms of ovarian cancer platinum resistance.

摘要

目的

研究核自体抗原精子蛋白(NASP)在铂耐药卵巢癌细胞克隆(C0C1/DDP)中的表达。

方法

采用高灵敏度二维差异凝胶电泳(2-D DIGE)结合基质辅助激光解吸电离飞行时间质谱(MALDI-TOF-MS)分离C0C1和C0C1/DDP的蛋白质,以鉴定在顺铂敏感和顺铂耐药细胞系中差异表达的蛋白质。

结果

研究者发现C0C1和C0C1/DDP之间存在一组差异表达的蛋白质。其中,NASP是下调21%的蛋白质之一(学生t检验;P = 0.01)。

结论

C0C1/DDP中NASP的鉴定为今后深入研究卵巢癌铂耐药机制奠定了基础。

相似文献

1
[Expression of nuclear autoantigenic sperm protein in platinum resistance ovarian cancer cell clones].核自身抗原性精子蛋白在铂耐药卵巢癌细胞克隆中的表达
Zhonghua Yi Xue Za Zhi. 2010 Jan 5;90(1):61-3.
2
[Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].[人卵巢癌细胞系及其铂耐药克隆的蛋白质组学分析]
Zhonghua Fu Chan Ke Za Zhi. 2006 Sep;41(9):584-7.
3
Identification of platinum-resistance associated proteins through proteomic analysis of human ovarian cancer cells and their platinum-resistant sublines.通过对人卵巢癌细胞及其铂耐药亚系进行蛋白质组学分析来鉴定铂耐药相关蛋白。
J Proteome Res. 2007 Feb;6(2):772-80. doi: 10.1021/pr060402r.
4
Quantitative differences in protein expression between cisplatin sensitive C0C1 ovarian carcinoma cells and cisplatin resistant C0C1/DDP cells.顺铂敏感的C0C1卵巢癌细胞与顺铂耐药的C0C1/DDP细胞之间蛋白质表达的定量差异。
Chin Med J (Engl). 2009 Apr 5;122(7):865-9.
5
Identification of reproducible low mass SELDI protein profiles specific to cisplatin resistance in human ovarian cancer cells.鉴定人卵巢癌细胞中对顺铂耐药具有特异性的可重复低质量SELDI蛋白质谱。
Oncol Rep. 2005 Nov;14(5):1323-30.
6
A proteomic kinetic analysis of IGROV1 ovarian carcinoma cell line response to cisplatin treatment.IGROV1卵巢癌细胞系对顺铂治疗反应的蛋白质组动力学分析。
Proteomics. 2007 Nov;7(22):4090-101. doi: 10.1002/pmic.200700231.
7
Mitochondrial comparative proteomics of human ovarian cancer cells and their platinum-resistant sublines.人卵巢癌细胞及其铂类耐药亚系的线粒体比较蛋白质组学。
Proteomics. 2010 Nov;10(21):3789-99. doi: 10.1002/pmic.200900685.
8
[Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP].[bcl-2反义寡脱氧核苷酸对卵巢癌细胞系A2780/DDP顺铂耐药逆转的研究]
Zhonghua Fu Chan Ke Za Zhi. 2006 Feb;41(2):121-5.
9
Suppression of hREV1 expression reduces the rate at which human ovarian carcinoma cells acquire resistance to cisplatin.
Mol Pharmacol. 2005 Jun;67(6):1852-60. doi: 10.1124/mol.104.010579. Epub 2005 Mar 9.
10
Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.肺耐药相关蛋白对人卵巢癌细胞系顺铂耐药性的影响。
Oncol Rep. 2004 Dec;12(6):1365-70.